Table 3 Distribution of HPV16 and other most prevalent genotypes in CIN lesions and ICC
HPV genotypes | ICC Total (%) n = 33 | CIN2-3 Total (%) n = 14 | CIN-1 Total (%) n = 12 | Controls Total (%) n = 20 |
|---|---|---|---|---|
HPV-16 only | 5 (15.1) | 1 (7.1) | 0 (0.0) | 1 (5.0) |
HPV16 with HPV-18 only | 5 (15.1) | 2 (14.2) | 0 (0.0) | 2 (10.0) |
HPV16 with HPV 18,35,45, or 31 | 20 (60.6) | 2 (14.2) | 1 (8.3) | 3 (15.0) |
HPV16 with HPV 18,31,33,35,45,52,58,68,82 | 30 (90.9) | 2 (14.2) | 1 (8.3) | 3 (15.0) |
HPV16 with HPV 6, 11,18,31,33,35,45,52,58,61,62,68,73,81,82 | 33 (100) | 3 (21.3) | 2 (16.6) | 4 (20.0) |
Other HR-HPV single infections 18,35,45,51,58,66 | 33 (100) | 4 (28.6) | 6 (50.0) | 8 (40.0) |
HPV 18,26,35,45,51,53,56,58,59,66, excluding HPV16 | 33 (100) | 13 (92.8) | 12 (100) | 18 (90.0) |
HPV 18,26,35,42,45,51,53,55,56,58,59,61,66,69,70,72,81,83,84, excluding HPV16 | 33 (100) | 14 (100) | 12 (100) | 20 (100) |